Approximately 80% of MG patients present with anti-AChR antibodies, while the remaining 20% include those with anti-MuSK or anti-LRP4 antibodies, or patients without detectable antibodies by routine testing, known as seronegative MG [3, 23]. This evidence concerns the gene LRP4 and myasthenia gravis.